Hussein Al‐Mossawi

2.1k citations

49 papers · 1.1k · h-index 14

Impact in

Rheumatology top 2%
- Spondyloarthritis Studies and Treatments
- Systemic Lupus Erythematosus Research
Immunology top 5%
- Psoriasis: Treatment and Pathogenesis
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology

Papers in

Rheumatology 29
- Spondyloarthritis Studies and Treatments 15
- Systemic Lupus Erythematosus Research 14
- Rheumatoid Arthritis Research and Therapies 5
Immunology 16
- Psoriasis: Treatment and Pathogenesis 9
- Immune Cell Function and Interaction 3

Co-authors: Paul Bowness (19 shared papers)Jelle de Wit (7 shared papers)Julian C. Knight (7 shared papers)Ariane Hammitzsch (6 shared papers)Benjamin P. Fairfax (5 shared papers)Davide Simone (6 shared papers)Hai Fang (3 shared papers)Chelsea Taylor (3 shared papers)
Journals: Annals of the Rheumatic Diseases (15 papers)The Lancet Rheumatology (3 papers)Nature Communications (3 papers)Lara D. Veeken (2 papers)Clinical and Experimental Rheumatology (2 papers)
Partner nations: United Kingdom United States Sweden

In The Last Decade

Hussein Al‐Mossawi

42 papers receiving 1.1k citations

Peers

Countries citing papers authored by Hussein Al‐Mossawi

Since Specialization

Citations

This map shows the geographic impact of Hussein Al‐Mossawi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hussein Al‐Mossawi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hussein Al‐Mossawi more than expected).

Fields of papers citing papers by Hussein Al‐Mossawi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hussein Al‐Mossawi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hussein Al‐Mossawi. The network helps show where Hussein Al‐Mossawi may publish in the future.

Co-authors

The 25 scholars most cited alongside Hussein Al‐Mossawi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hussein Al‐Mossawi Line = papers co-authored together Hussein Al‐Mossawi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Peripheral CD8+ T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma Nature Medicine ·Benjamin P. Fairfax, Chelsea Taylor, Robert Watson, Isar Nassiri, Sara Danielli, Hai Fang, Elise A. Mahé, Rosalin Cooper, Victoria K. Woodcock, Zoë Traill, Hussein Al‐Mossawi, Julian C. Knight, Paul Klenerman, Miranda Payne, Mark R. Middleton	2020	206
2	CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses Proceedings of the National Academy of Sciences ·Ariane Hammitzsch, C. Tallant, O. Fedorov, Alison O’Mahony, Paul E. Brennan, Duncan A. Hay, Fernando O. Martínez, Hussein Al‐Mossawi, Jelle de Wit, Matteo Vecellio, Christopher Wells, B P Wordsworth, Susanne Müller, Stefan Knapp, Paul Bowness	2015	206
3	Unique transcriptome signatures and GM-CSF expression in lymphocytes from patients with spondyloarthritis Nature Communications ·Hussein Al‐Mossawi, L. Chen, Hai Fang, Anne J. Ridley, Jelle de Wit, Nicole Yager, Ariane Hammitzsch, Irina Pulyakhina, Benjamin P. Fairfax, Davide Simone, Yao Yi, Soham Bandyopadhyay, K Doig, Roger Gundle, Benjamin Kendrick, Fiona Powrie, Julian C. Knight, Paul Bowness	2017	116
4	Multi-omic single cell analysis resolves novel stromal cell populations in healthy and diseased human tendon Scientific Reports ·Adrian Kendal, T. B. Layton, Hussein Al‐Mossawi, Louise Appleton, Stephanie G. Dakin, Rick Brown, Constantinos Loizou, Mark Rogers, Robert Sharp, Andrew Carr	2020	100
5	A Randomized, Placebo‐Controlled Phase III Extension Trial of the Long‐Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus Arthritis & Rheumatology ·Kenneth Kalunian, Richard Furie, Eric F. Morand, Ian N Bruce, Susan Manzi, Yoshiya Tanaka, Kevin Winthrop, Ihor Hupka, Lijin Zhang, Shanti Werther, Gabriel Abreu, Micki Hultquist, Raj Tummala, Catharina Lindholm, Hussein Al‐Mossawi	2022	91
6	miR-10b-5p is a novel Th17 regulator present in Th17 cells from ankylosing spondylitis Annals of the Rheumatic Diseases ·L Chen, Hussein Al‐Mossawi, Anne J. Ridley, Takuya Sekine, Ariane Hammitzsch, Jelle de Wit, Davide Simone, Hui Shi, Frank Penkava, Mariola Kurowska‐Stolarska, Irina Pulyakhina, Julian C. Knight, Tae‐Jong Kim, Paul Bowness	2016	60
7	Activation‐Induced Killer Cell Immunoglobulin‐like Receptor 3DL2 Binding to HLA–B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis Arthritis & Rheumatology ·Anna Ridley, Hiroko Hatano, Isabel Wong‐Baeza, Jacqueline Shaw, Katherine Matthews, Hussein Al‐Mossawi, Kristin Ladell, David A. Price, Paul Bowness, Simon Kollnberger	2015	40
8	Type I interferon blockade with anifrolumab in patients with systemic lupus erythematosus modulates key immunopathological pathways in a gene expression and proteomic analysis of two phase 3 trials Annals of the Rheumatic Diseases ·Tina Baker, Hoda Sharifian, Paul J. Newcombe, Patrick G. Gavin, Mark Lazarus, Madhu Ramaswamy, Wendy I. White, Nicola Ferrari, Daniel Muthas, Raj Tummala, Eric F. Morand, Richard Furie, Edward M Vital, Chris Chamberlain, Adam Platt, Hussein Al‐Mossawi, Philip Z. Brohawn, Eszter Csomor	2024	39
9	Single cell analysis of spondyloarthritis regulatory T cells identifies distinct synovial gene expression patterns and clonal fates Communications Biology ·Davide Simone, Frank Penkava, Anna Ridley, Stephen N. Sansom, Hussein Al‐Mossawi, Paul Bowness	2021	38
10	Inhibiting ex-vivo Th17 responses in Ankylosing Spondylitis by targeting Janus kinases Scientific Reports ·Ariane Hammitzsch, Liye Chen, Jelle de Wit, Hussein Al‐Mossawi, Anna Ridley, Takuya Sekine, Davide Simone, Karen Doig, Alla Skapenko, Paul Bowness	2018	35
11	Context-specific regulation of surface and soluble IL7R expression by an autoimmune risk allele Nature Communications ·Hussein Al‐Mossawi, Nicole Yager, Chelsea Taylor, Evelyn Lau, Sara Danielli, Jelle de Wit, James J. Gilchrist, Isar Nassiri, Elise A. Mahé, Wanseon Lee, Laila Rizvi, Seiko Makino, Jane Cheeseman, Matt J. Neville, Julian C. Knight, Paul Bowness, Benjamin P. Fairfax	2019	33
12	Ex vivo mass cytometry analysis reveals a profound myeloid proinflammatory signature in psoriatic arthritis synovial fluid Annals of the Rheumatic Diseases ·Nicole Yager, Suzanne Cole, Alicia Lledó Lara, Ash Maroof, Frank Penkava, Julian C. Knight, Paul Bowness, Hussein Al‐Mossawi	2021	30
13	Differential regulation of IL-17A and IL-17F via STAT5 contributes to psoriatic disease Journal of Allergy and Clinical Immunology ·Suzanne Cole, Avneet Manghera, Lachrissa A. Burns, Janine Barrett, Nicole Yager, Hefin Rhys, Andrew Skelton, John Cole, Carl S. Goodyear, Meryn Griffiths, Dominique Baeten, Marta Bertolini, Stevan Shaw, Hussein Al‐Mossawi, Asher Maroof	2023	25
14	Targeting DORIS Remission and LLDAS in SLE: A Review Rheumatology and Therapy ·Agner R. Parra Sánchez, Ronald van Vollenhoven, Eric F. Morand, Ian N Bruce, Rangi Kandane‐Rathnayake, Gudrun Weiss, Raj Tummala, Hussein Al‐Mossawi, Alessandro Sorrentino	2023	15
15	The long-term safety and tolerability of anifrolumab for patients with systemic lupus erythematosus in Japan: TULIP-LTE subgroup analysis Modern Rheumatology ·Yoshiya Tanaka, Tatsuya Atsumi, Masato Okada, Tomoya Miyamura, Tomonori Ishii, Susumu Nishiyama, Ryutaro Matsumura, Atsushi Kawakami, Nobuya Hayashi, Gabriel Abreu, Şule Yavuz, Catharina Lindholm, Hussein Al‐Mossawi, Tsutomu Takeuchi	2023	9
16	Novel Therapeutic Targets in Axial Spondyloarthritis PubMed ·Claudia Worth, Paul Bowness, Hussein Al‐Mossawi	2018	8
17	Treating to target in psoriatic arthritis: assessing real-world outcomes and optimising therapeutic strategy for adults with psoriatic arthritis—study protocol for the MONITOR-PsA study, a trials within cohorts study design Trials ·Ines Rombach, William Tillett, Deepak R. Jadon, Laura Tucker, Marion Watson, Anne Francis, Yvonne Sinomati, Lucy Eldridge, Melina Dritsaki, Susan Dutton, Hussein Al‐Mossawi, Nicola Gullick, Ben Thompson, Laura C. Coates	2021	8
18	Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trial The Lancet Rheumatology ·Claudia Worth, Hussein Al‐Mossawi, Jo-Anne MacDonald, Benjamin A. Fisher, Antoni Chan, Raj Sengupta, Jon Packham, Karl Gaffney, Nicola Gullick, Jonathan Cook, T. H. Corn, James Teh, Pedro Machado, Peter C. Taylor, Paul Bowness	2024	7
19	OP0051 LUPUS LOW DISEASE ACTIVITY STATE ATTAINMENT IN THE PHASE 3 PLACEBO-CONTROLLED TULIP LONG-TERM EXTENSION TRIAL OF ANIFROLUMAB Annals of the Rheumatic Diseases ·Eric F. Morand, Ronald van Vollenhoven, Richard Furie, Kenneth Kalunian, Şadan Yavuz, Gabriel Abreu, C. Lindholm, Hussein Al‐Mossawi	2023	6
20	Optimising psoriatic arthritis therapy with immunological methods to increase standard evaluation: the protocol of an open-label multicentre, parallel-group, two-arm randomised controlled study evaluation precision medicine approach in the treatment of psoriatic arthritis BMJ Open ·Alexander Ooms, Hussein Al‐Mossawi, Louise Bennett, Mimi Bogale, Paul Bowness, Anne Francis, Carl S. Goodyear, Bruce Kirkham, Sylvine Lalnunhlimi, Iain B. McInnes, Duncan Richards, Stefan Siebert, Leonie S. Taams, Aysın Tulunay Virlan, Nicole Yager, Laura C. Coates	2023	5

About Hussein Al‐Mossawi

Hussein Al‐Mossawi is a scholar working on Rheumatology, Immunology, Hematology, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 49 papers that have together received 1.1k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (15 papers), Systemic Lupus Erythematosus Research (14 papers), Psoriasis: Treatment and Pathogenesis (9 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Autoimmune and Inflammatory Disorders Research (6 papers), Rheumatoid Arthritis Research and Therapies (5 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Rheumatology (370 citations), Immunology (441 citations), Hematology (153 citations), Orthopedics and Sports Medicine (87 citations) and Oncology (240 citations). Hussein Al‐Mossawi has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Paul Bowness, Jelle de Wit, Julian C. Knight, Ariane Hammitzsch, Benjamin P. Fairfax, Davide Simone, Hai Fang, Chelsea Taylor, Isar Nassiri and Elise A. Mahé. Their work appears in journals such as Annals of the Rheumatic Diseases, The Lancet Rheumatology, Nature Communications, Lara D. Veeken and Clinical and Experimental Rheumatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Hussein Al‐Mossawi

Impact in

Papers in i

In The Last Decade

Hussein Al‐Mossawi

Peers

Countries citing papers authored by Hussein Al‐Mossawi

Fields of papers citing papers by Hussein Al‐Mossawi

All Works

About Hussein Al‐Mossawi

Explore authors with similar magnitude of impact

Papers in